BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12934106)

  • 1. Ceramide-mediated clustering is required for CD95-DISC formation.
    Grassmé H; Cremesti A; Kolesnick R; Gulbins E
    Oncogene; 2003 Aug; 22(35):5457-70. PubMed ID: 12934106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis.
    Scheel-Toellner D; Wang K; Assi LK; Webb PR; Craddock RM; Salmon M; Lord JM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):679-81. PubMed ID: 15493986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis.
    Dumitru CA; Gulbins E
    Oncogene; 2006 Sep; 25(41):5612-25. PubMed ID: 16636669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.
    Martin S; Phillips DC; Szekely-Szucs K; Elghazi L; Desmots F; Houghton JA
    Cancer Res; 2005 Dec; 65(24):11447-58. PubMed ID: 16357153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of ceramide-mediated CD95 clustering.
    Grassmé H; Schwarz H; Gulbins E
    Biochem Biophys Res Commun; 2001 Jun; 284(4):1016-30. PubMed ID: 11409897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
    Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
    J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
    Lacour S; Hammann A; Grazide S; Lagadic-Gossmann D; Athias A; Sergent O; Laurent G; Gambert P; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2004 May; 64(10):3593-8. PubMed ID: 15150117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD95(APO-1/Fas) DISC and beyond.
    Peter ME; Krammer PH
    Cell Death Differ; 2003 Jan; 10(1):26-35. PubMed ID: 12655293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological aspects of ceramide-enriched membrane domains.
    Grassmé H; Riethmüller J; Gulbins E
    Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperosmotic activation of the CD95 system.
    Reinehr R; Häussinger D
    Methods Enzymol; 2007; 428():145-60. PubMed ID: 17875416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rewinding the DISC.
    Chaigne-Delalande B; Moreau JF; Legembre P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):9-14. PubMed ID: 18250974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.
    Eramo A; Sargiacomo M; Ricci-Vitiani L; Todaro M; Stassi G; Messina CG; Parolini I; Lotti F; Sette G; Peschle C; De Maria R
    Eur J Immunol; 2004 Jul; 34(7):1930-40. PubMed ID: 15214041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8.
    Barnhart BC; Pietras EM; Algeciras-Schimnich A; Salmena L; Sayama K; Hakem R; Peter ME
    Cell Death Differ; 2005 Jan; 12(1):25-37. PubMed ID: 15499374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
    Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
    Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death or survival: membrane ceramide controls the fate and activation of antigen-specific T-cells depending on signal strength and duration.
    Detre C; Kiss E; Varga Z; Ludányi K; Pászty K; Enyedi A; Kövesdi D; Panyi G; Rajnavölgyi E; Matkó J
    Cell Signal; 2006 Mar; 18(3):294-306. PubMed ID: 16099142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic mercury dissociates preassembled Fas/CD95 receptor oligomers in T lymphocytes.
    Ziemba SE; McCabe MJ; Rosenspire AJ
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):334-42. PubMed ID: 16039944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
    Eberle A; Reinehr R; Becker S; Häussinger D
    Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to analyze the palmitoylated CD95 high molecular weight death-inducing signaling complex.
    Feig C; Peter ME
    Methods Enzymol; 2008; 442():83-100. PubMed ID: 18662565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The active caspase-8 heterotetramer is formed at the CD95 DISC.
    Lavrik I; Krueger A; Schmitz I; Baumann S; Weyd H; Krammer PH; Kirchhoff S
    Cell Death Differ; 2003 Jan; 10(1):144-5. PubMed ID: 12655304
    [No Abstract]   [Full Text] [Related]  

  • 20. Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms.
    Dumitru CA; Carpinteiro A; Trarbach T; Hengge UR; Gulbins E
    Apoptosis; 2007 Aug; 12(8):1533-41. PubMed ID: 17520194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.